1. Introduction
Coronavirus disease-19 (COVID-19) is regarded as an infective-inflammatory disease that affects mainly the lungs. It is currently unclear whether the initial pathological viral process begins in the lungs, causing general hypoxia and iron dysmetabolism.
Hemoglobin/iron dysmetabolism is likely to be the leading process causing multiorgan disease and hypoxia. In this regard, it should be noted that there is a similarity between the distal amino acid sequence of the SARS-CoV-2 spike glycoprotein cytoplasmic tail and the hepcidin protein [
1]. In this way, iron metabolism is changed, which leads to iron dysmetabolism and ferroptosis [
2]. Apart from that, there are additional pathological metabolic pathways resulting from hemoglobin denaturation, based on predictions suggesting that the virus attacks the hemoglobin in red blood cells [
3,
4]. The SARS-CoV-2 virus interacts with the erythrocyte receptors such as cyclophilins, furins, TMPRSS2, and CD147 (in addition to the recognized ACE2) [
5,
6], penetrates the cells, and interacts with the hemoglobin.
Theoretical modeling has shown [
7] that ORF1ab, ORF10, and ORF3a proteins could dissociate iron to form porphyrin while ORF8 and surface glycoprotein could bind to the porphyrin. The theoretical model used has shown that structural proteins do not bind to hemoglobin. However, it has been recently proved experimentally that S binds to Hb [
8]. It has been found what part of RDB and the N-terminal domain (NTD) of the SARS-CoV-2 spike is responsible for binding the α and β chain of Hb. The assay involved SARS-CoV-2-infected Vero cell extracts incubated with Hb by means of the shotgun proteomics method. In silico analysis has been used to identify Hb binding motifs in the nucleoprotein.
Hemoglobin/iron dysmetabolism has been considered a leading process caused by a virus infection that results in multi-organ disease, so antibodies, vaccines, and inhibitors targeting potential pathophysiological pathways have been proposed [
9]. Developing methods to study the possible molecular interactions is of primary importance. [
10] explores the idea of a link between SARS-CoV-2 and protoporphyrin, so detection of the latter has been proposed as a diagnostic tool for infection.
Different sensing platforms can be used to study the binding behavior of SARS-CoV-2 proteins, two of the most effective being those based on surface plasmon resonance (SPR) and double resonance long-period gratings (DR LPG), both of which are highly sensitive to changes in the surrounding refractive index. Thus SPR has been successfully used for SARS-CoV-2 diagnosis [
11,
12,
13]. Hemoglobin-functionalized SPR and DR LPGs transducers have been shown to be a sensitive platform for glucose sensing [
14]. LPGs have been successfully used to detect SARS-CoV-2 S-proteins [
15] and have been successfully applied for both bacteria and virus detection [
16,
17].
The aim of our study was to provide new additional experimental data on the mechanisms of binding of SARS-CoV-2 S/N structural proteins and RBD protein, as well as of VLPs to Hb/Mb. The aim of this study was also to predict or shed light upon the biological role of proteins and the clinical manifestation of viral disease, as well as on the possibilities of early diagnosis of infection. As a consequence, we formulated two hypotheses of biological and medical importance.
Given the availability of very few experimental results in the research area, our aim was, by using physical methods of detection, to confirm the results that have been previously obtained by biochemical methods. Unlike the experiments known so far in the field, ours were based on registering physical phenomena based on the direct molecular interactions of S/N proteins, RBD proteins, and VLPs with Hb/Mb, which take place on SPR and DR LPG transducers. Achieving corroborating results would remove any doubt regarding the correctness of such complex experiments.
Our study also aimed to establish a single standard protocol regarding ligands immobilization, bioactive substance manipulation, and measurement procedures. We evaluated the effectiveness of the protocols by obtaining consistent experimental results from two different detection systems, namely the SPR and the DR LPG systems.
2. Materials and Methods
2.1. Reagents and Materials
All the chemicals and reagents used were of analytical grade. The following SARS-CoV-2 specific structural proteins were used to evaluate the bimolecular interaction:
2.1.1. SARS-CoV-2 Spike S1 Subunit Protein
The SARS-CoV-2 Spike S1 subunit protein fused to a C-terminal poly-histidine (6 × Histidine) tag with a tri-amino acid linker (Molecular weight (Mw)~123 kDa) was purchased from InvivoGen Company, (San Diego, CA, USA), 5, rue Jean Rodier F-31400 Toulouse France. Stock solutions for the experiments were prepared at an initial concentration of 100 µg/mL deionized water. Aliquots were prepared and stored at −20 °C until use. Working concentrations were propagated in fresh deionized water in the concentration range of 20 fM–800 fM.
2.1.2. SARS-CoV-2 Nucleocapsid Protein
The SARS-CoV-2 nucleocapsid protein fused to IgG1 Fc tag with a TEV (Tobacco etch virus) sequence linker (Mw~79 kDa) was purchased from InvivoGen Company, USA. Stock solutions were prepared at an initial concentration of 100 µg/mL in deionized water. Aliquots were stored at −20 °C until use. Working concentrations of the stock solution were dissolved in fresh deionized water in the concentration range of 30 fM–810 fM.
2.1.3. Hemoglobin and Myoglobin
Hb (from bovine blood, H2500) and Mb (from equine skeletal muscle, M0630) were purchased from Sigma-Aldrich (Sofia, Bulgaria, FOT Ltd.-representative).
2.1.4. SARS-CoV-2 Spike-RBD (Receptor Binding Domain)
The soluble SARS-CoV-2 Spike-RBD protein fused to a C-terminal poly-histidine (6 × Histidine) tag with a 3 amino acid linker (Spike-RBD-His) (Mw~30 kDa) was purchased from InvivoGen Company, San Diego, CA, USA. Stock solutions for the experiments were prepared at an initial concentration of 100 µg/mL of deionized water. Aliquots were prepared and stored at −20 °C until use. Working concentrations of the stock solution were dissolved in fresh deionized water in the concentration range of 20–800 fM.
2.1.5. Chemically-Inactivated Virus-like Particles (VLPs)
Chemically-inactivated VLPs, 500 µL tube, were purchased from (Microbiologics, San Diego, CA, USA). β-propiolactone chemical inactivator is used for SARS-CoV-2 virus inactivation. Working concentrations of the stock solution were dissolved in DEPC-treated water in the concentration range of 1:1000, 1:2500, 1:5000, and 1:10,000, which correspond to RNA copies/mL, respectively 411,800, 356,800, 42,640, and 44,530. Viral RNA was extracted by an automatic extraction system using the ExiPrep Dx Viral DNA/RNA kit (Bioneer, Daejeon, Republic of Korea) in accordance with the manufacturer’s instructions. The detection was provided by real-time RT-PCR using a CFX96 thermal cycler (Bio-Rad Laboratories, Inc., Hercules, CA, USA) and TaqPath COVID-19 CE-IVD PCR Kit (Thermo Fisher Scientific, Waltham, MA, USA).
2.2. Surface Plasmon Resonance Method
In our experiment SPR was excited on the surface of a gilded diffraction grating, as shown schematically in
Figure 1. The gratings were supplied by DEMAX Ltd., Sofia, Bulgaria; for the purposes of the experiment, we covered them with 110 nm ± 10 nm gold film coating obtained by vacuum evaporation. SPR conditions were fulfilled for a P-polarized light beam that illuminated the grating at an incidence angle of 35 degrees. Typically, the resonance was excited in the range of 690–705 nm for a bare grating having 80 nm-high grooves and a period of 1.55 µm. The SPR chip represents the gilded grating covered with Hb or Mb of a certain thickness, as shown in
Figure 1.
Details about the SPR measurement system based on spectrum readout can be found in [
18]. The spectrometer accuracy measurement is 0.2 nm, while the overall accuracy of the resonance shift measurement of the SPR system is appraised at about 2 nm. The limit of detection (LOD) was evaluated by considering the accuracy of the spectrometer as well as the accuracy of the goniometer for setting up the angle of light incidence.
2.3. Double Resonance Long-Period Gratings (DR LPGs)
2.3.1. Principle of Operation of Double Resonance Gratings around the Turning Point
A long-period grating (LPG) is a structure consisting of a sequence of modulations with a period Λ of the refractive index and/or the geometric dimensions of the core and cladding of a stripped optical fiber. The modulations cause coupling between the fundamental LP
01 core mode of an effective refractive index
n01 and an LP
0p higher-order cladding mode of the glass/air waveguide of an effective refractive index
n0p. The higher order LP
0p cladding mode is attenuated in the subsequently coated fiber region, so a total loss is observed at the fiber end. The coupling reaches a maximum at a center wavelength
at which a minimum of the transmission spectrum is observed. As seen from (1), the center wavelength is proportional to the period which is a unique geometrical quantity, not dependent on the wavelength. Because of dispersion, for a given grating period Λ the effective refractive index difference Δ
neff can have two different values, Δ
neff,1 and Δ
neff,2, at two different wavelengths, due to which two resonance wavelengths
λc1 and
λc2 can occur for the same grating period, as shown in
Figure 2a. Thus (1) becomes:
The point where
λc1 =
λc2 is indicated in
Figure 2a as the turn-around point (TAP) wavelength at the grating period Λ
0p of the mode LP
0p. For the 11th cladding mode, LP
0,11 of the photosensitive fiber PS1250/1500 (Fibercore) Λ
0,11 ≈ 207.7 μm.
Figure 2b shows the evolution of the LPG spectrum with a period Λ at the turning point. The spectrum deepens and splits as either the temperature or the surrounding refractive index increase which leads to an increase in the spectral separation Δ
λ =
λc2 −
λc1. The change of Δλ with SRI is the basis for label-free biosensors.
2.3.2. Fabrication and Calibration Procedure
First, the DR LPGs were fabricated using a SYNRAD pulsed CO2 laser (λ = 10.6 μm, f = 20 kHz, at 13.1% to 14% of maximum power, a focal length of the scanning head is 10 cm and a spot size of about 100 μm). A NKT Photonics Super K Compact white light source (purchased from NKT Photonics Inc, 23 Drydock Ave, Boston, MA 02210, USA) and a Yokogawa AQ 6370C optical spectrum analyzer (OSA) were used to monitor the formation of the grating spectrum during the inscription process of the grating with Λ = 207.6 μm and N from 235 to 250. A section of a photosensitive PS 1250/1500 (Fibercore) with a length l0 = 10 cm was spliced between a lead-in and a lead-out SMF-28E single mode fiber each of 1 m. A weight of m = 4 g was attached to the fiber to guarantee repeatability in the fiber longitudinal strain.
Second, after fabrication, the LPG was immersed in water to check if the desired double resonance spectrum was achieved.
Third, the grating was placed in a 10% solution of HF acid and the split was reduced to the desired position around the turning point.
Fourth, after the grating was tuned closer to TAP, its sensitivity to SRI around the water was measured at a temperature of 23 °C. The spectral separation Δ
λ =
λc2 −
λc1 between the minima as a function of the SRI
n in the 1.33–1.35 range was found to be in the form
In (3)
A is a constant and
Sn is the SRI sensitivity. Four of the fabricated DR LPGs under consecutive fabrication numbers P093, P095, P097, and P100 were further functionalized using the procedure described in the next
Section 2.4.
Table 1 below summarizes the individually measured SRI sensitivities
Sn and the type of ligand used to functionalize the gratings using a pulsed laser deposition technique.
After their functionalization, the gratings were placed in the measurement set-up, using the same weight and temperature as in the calibration measurement.
The spectral separation was measured in air and water immediately after immersion in water and 5 min later and is referred to as Δλ0. The 5 min waiting period allows the grating to reach thermodynamic equilibrium in the liquid.
2.4. Deposition of Bioactive Ligands
Our experiment involved ligands of Hb and Mb molecules deposited on SPR gratings and only Hb deposited on LPG structures. Matrix-assisted laser evaporation (MAPLE) was used for the ligand deposition to avoid build-in matrix and related mediating molecules—the main causes for biosensor non-specific response. Details about the MAPLE technology and Hb/Mb immobilization can be found in [
19,
20]. Hemoglobin was deposited simultaneously on DR LPG structures (with their sensitivities measured in advance) and on SPR gratings. The LPG and SPR transducers were placed in a vacuum camera in groups of eight and were subsequently functionalized by the MAPLE technique. The SPR grating was Mb-functionalized at another MAPLE deposition.
For the direct Hb/Mb immobilization, a frozen solution target involving 5–7% Hb/Mb in deionized water was used. The main challenge in MAPLE deposition is whether the laser transfer preserves the bioactivity of the deposited molecules. To prove that the deposited protein layers preserve their functionality, the SPR biochips were blown with carbon monoxide (CO) and nitrogen monoxide (NO). The resonance spectral shift registered (in the range of 1–3 nm), which was due to the coupling of CO/NO with the heme/thiol groups, proved the bioactivity of the immobilized molecules.
2.5. Incubation of SPR Chips and Measurement Procedure
In addition to the simultaneous functionalization of the SPR gratings and the LPG structures, two other MAPLE depositions were performed to functionalize the SPR gratings. A total of 48 SPR biochips were examined in order to establish the measurement accuracy, out of which 36 were Hb-functionalized and 12 were Mb-functionalized.
The biochips functionalized with Hb were incubated as follows: 12—with S protein of different concentrations, 12—with N protein of different concentrations, and 12—with RBD protein of different concentrations.
The group of biochips functionalized with Mb was divided into two sets, and incubated with S- and N-proteins, respectively.
The biochips were incubated for 20 min at room temperature, then they were washed with deionized water (<2 µS/cm), after which the liquid phase was removed by centrifugation. All treatments were performed under the same conditions.
After the gilded diffraction gratings were functionalized, the plasmon resonances were measured at six different points on the biochip surface to evaluate the quality of the ligand layer. The spectral position of the resonances at each point was taken as a reference against which the shift due to the Hb/Mb—protein interaction was registered.
After incubation, the plasmon resonances were measured at the same si = x points on the biochip surface and the resonance wavelength shifts were estimated as differences from the reference resonances. Then the corresponding displacement average values and the absolute measurement errors were determined.
2.6. Incubation of LPG Structures and Measurement Procedure
DR LPG structures were incubated with SARS-CoV-2 structural proteins and RBD proteins at different concentrations. Four structures were incubated with S proteins, four—with N proteins, and four—with RBD proteins.
The spectra for each protein, starting from the lowest and going to the highest concentration, were consecutively measured. Measurements were performed immediately after the immersion into a particular concentration, 2.5 min later, and at the 5th min. The first LPG structure was incubated with all the protein concentrations. The incubation of the second structure started with the second higher concentration, then went up until the highest one was reached. The incubation of the third structure started with the third higher concentration. The fourth structure was incubated only with the highest concentration. The measurement results of each structure for the respective concentration were compared and good repeatability was observed. After measuring the highest concentration, the spectra in both water and air were re-measured.
Unlike SPR, DR LPG provides real-time measurement. To establish the correctness of the measurement procedure, the LPG transducer was washed after each incubation. The results were compared with those without washing.
The spectral separation Δ
λ =
λc2 −
λc1 for each concentration was determined, after which the change of the spectral separation at a given concentration Δ
λi with respect to that in water Δ
λ0 was defined as
Since the accumulation of the detected protein increased the refractive index on the grating surface, the spectral changes
δλi were converted into refractive index changes
δni for the corresponding concentration by taking into account the sensitivity
Sn of the particular grating. From (4) and (3) it follows that
Ultimately, the dependence
δni(
Ci) is plotted for each protein.
4. Conclusions
The experimental results presented here imply that SARS-CoV-2 structural proteins and the virus itself actively bind here and completely inhibit its function. This causes poor clinical outcomes, as it is a ubiquitous molecule with an important role in many biological processes. Some of them, such as abnormal heme metabolism and oxygen transport can be registered long before the acute phase of infection. This is a consequence of the observed binding activity to Hb which is much higher than the binding to the monoclonal antibodies, as reported in a recent paper of ours [
23]. In support of this hypothesis, it is worth mentioning that the common viral loads for COVID-19-positive patients have been found to be in the range of 10
6–10
11 RNA copies/mL [
24], while we observed a pronounced binding at 10
4 RNA copies/ml.
Due to their low specificity, the reactions studied cannot be used for diagnosing infection from clinical samples. However, their high affinity makes them perfect for assessing the effectiveness of inhibitors targeting S/N proteins. Since a number of potential antibodies directed to S-RBD, S-NTD, and N-NTD have been identified, such an evaluation approach can prevent further frustration in clinical trials. The real-time monitoring of biomolecular interactions performed by the DR LPG sensing platform is of great advantage in such studies.
The reported data demonstrate that SPR and DR LPG can detect proteins with a limit of detection reaching several tens of fM. This is in contrast to the 130 fM, achieved by the SPR detection based on antibody-antigen interaction, as reported in a recent paper of ours [
23]. This comparison is admissible since constant concentrations of ligands and proteins were maintained in our experiments. The above-mentioned difference is due to the higher binding affinity of Hb/Mb. The detectable levels achieved at different sensing assays and the steady results obtained by the demonstrated biosensor platforms prove the correctness and consistency of the protocols applied for immobilization, bioactive material handling, and measurement procedures.